Professor Gerd Gigerenzer of the Max Planck Institute for Human Development in Berlin is one of the world’s leaders in risk communication. He teaches doctors, policy-makers, journalists and the general public. He has written before about how misleading communication of risk is a moral issue for medical journals, for journalists, for researchers, and for anyone [...]
Michael Kirsch, M.D, who blogs as MD Whistleblower, offers an educational insight about surrogate markers – especially helpful if you don’t know much about these. And, in his estimation, many news stories don’t seem to reflect much knowledge on the topic. Excerpt: Why do some medical studies, which achieve breaking news status, often fall so [...]
Dr. Len’s Cancer Blog, written by Dr. Len Lichtenfeld, Deputy Chief Medical Officer of the American Cancer Society, offers a terrific example of how to scrutinize confidence intervals in a study. He commented on a study that got a lot of news coverage – suggesting that women with breast cancer who took tamoxifen had 440% [...]
Dr. Nancy Snyderman of NBC News appeared on the Today Show with Matt Lauer last week, profiling a physician-author who has written that the best science does not establish a causal link between childhood vaccines and autism. Lauer, in a followup question, mis-spoke and called it a “casual” link – not causal. One wonders whether [...]
It’s difficult to do an overview of melanoma drug research in a relatively brief story. But this story did a solid job.
Better than a competing piece by Reuters but still a little short on some details about this asthma drug study.
An adequate summary of this asthma drug trial’s design doesn’t make up for the overly optimistic tone about the drug’s future. A New York Times story was better.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2013 Health News Review
